Medication for Addiction Treatment During COVID-19
As overdose rates rise, we need addiction treatment in hospitals now more than ever. This guidance outlines how to implement medication for addiction treatment (MAT) during predicted COVID-19 surges.
New HHS Practice Guidelines
Here’s the most important takeaway of the “HHS Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder”: All prescribers with a valid state license and DEA can register for an X wavier without mandatory training.
Blueprint for Hospital Opioid Use Disorder Treatment
This comprehensive resource is scalable for any health system, based on our model implemented at diverse sites that demonstrate feasibility at large and small, public and private, urban, and rural hospitals.
Be The Changemaker: Bootcamp For Champions
14 Oct 2021, 11:00 am
Let’s Talk Alcohol Use Disorder & Polysubstance Use
Since its inception, CA Bridge has fielded hundreds of inquiries about treating patients with alcohol use disorder and other co-occurring substance use. Turns out, many patients do not use just one substance at a time! This session will explore what we know about evidence-based treatment for alcohol and answer participant questions about treating polysubstance use.
This series offers CME for physicians and self-reported hours for other clinicians.